The Ministry of Health of the Russian Federation has developed a draft law on the introduction of mandatory ethical review for biotechnological medicinal products (BTMP), which will take effect on September 1, 2026. The document was published for public discussion on Wednesday.
According to the draft, a special committee will be created to assess the use of such drugs. BTMPs are made individually for each patient in a medical organization using their own cells or tissues. They are used to treat life-threatening diseases, including oncological, autoimmune, and cardiovascular diseases.
As indicated in the explanatory note, the purpose of the ethical review is to guarantee the safety and protection of patients' rights. The committee will assess the appropriateness of the drug's use, the patient's awareness of the risks and benefits, and the absence of conflicts of interest.
The initiative was prepared on the instructions of Deputy Prime Minister Tatyana Golikova. Currently, such drugs are used selectively, mainly in federal centers as part of scientific research or internal protocols.
Read more on the topic:
Rostec supplied 85 thousand units of equipment to medical institutions in the country
Now on home
The state has accelerated the introduction of unmanned solutions, integrating them into the real sector of the economy
Modernized engines may equip the Lada Azimut crossover
The price is 132 billion 265.8 million rubles
The manufacturer plans to strengthen its lineup of light commercial vehicles
The production of carbon fiber was organized in the shortest possible time
Electric vans will speed up the repair of urban transport infrastructure
Countries are working to synchronize regulations in the field of AI
The service's average daily audience is 55 million people
Stable Isomaterial Based on Metakaolin Has a Density Below 300 kg/m³
Re-identification quality improved twofold with new DynaMix method
Russians will be able to find out about debts online
The company presented the new crossover in Moscow and announced the launch dates for mass production